OS Therapies Statistics
Total Valuation
OS Therapies has a market cap or net worth of $55.49 million. The enterprise value is $72.09 million.
Important Dates
The next estimated earnings date is Friday, November 15, 2024, before market open.
Earnings Date | Nov 15, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
OS Therapies has 20.88 million shares outstanding. The number of shares has increased by 8.92% in one year.
Shares Outstanding | 20.88M |
Shares Change (YoY) | +8.92% |
Shares Change (QoQ) | -47.49% |
Owned by Insiders (%) | 17.82% |
Owned by Institutions (%) | 0.54% |
Float | 16.53M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | 362.68 |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.05
Current Ratio | 0.05 |
Quick Ratio | 0.00 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -0.98 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.64M |
Employee Count | 4 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | 3.38 |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 34.02 |
Average Volume (20 Days) | 25,859 |
Short Selling Information
The latest short interest is 8,931, so 0.04% of the outstanding shares have been sold short.
Short Interest | 8,931 |
Short Previous Month | n/a |
Short % of Shares Out | 0.04% |
Short % of Float | 0.05% |
Short Ratio (days to cover) | 0.01 |
Income Statement
Revenue | n/a |
Gross Profit | -5,154 |
Operating Income | -3.19M |
Pretax Income | n/a |
Net Income | -6.55M |
EBITDA | -3.18M |
EBIT | -3.19M |
Earnings Per Share (EPS) | -$0.60 |
Full Income Statement Balance Sheet
The company has $94,925 in cash and $16.70 million in debt, giving a net cash position of -$16.60 million or -$0.80 per share.
Cash & Cash Equivalents | 94,925 |
Total Debt | 16.70M |
Net Cash | -16.60M |
Net Cash Per Share | -$0.80 |
Equity (Book Value) | -27.06M |
Book Value Per Share | -4.52 |
Working Capital | -26.97M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$3.27 million and capital expenditures $19, giving a free cash flow of -$3.27 million.
Operating Cash Flow | -3.27M |
Capital Expenditures | 19 |
Free Cash Flow | -3.27M |
FCF Per Share | -$0.16 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |